CN204815326U - Boosting formula vagina of preventing superinfection ware of dosing - Google Patents

Abstract

The utility model discloses a booster type vaginal drug delivery device for preventing secondary infection; it comprises a drug-adding syringe and a drug-administering head; the drug-adding syringe includes a syringe, a piston handle and a telescopic protective cover; the front end of the syringe is connected with a nipple ; the rear end of the syringe is formed as an opening; the piston handle is accommodated in the syringe, and the end of the piston handle is exposed to the opening; The ends are connected so that the front end of the piston handle can be fixed in the syringe in an airtight manner; There are multiple overflow holes on the outer wall of the front end of the drug head; the effect: directly insert the drug delivery tube into the patient's vagina, so that the drug can reach the lesion evenly, and the patient will not feel tingling when it is inserted, because The front and rear ends of the syringe are sealed so that when the drug is injected into the patient's vagina, there will be no cross-infection and secondary infection in the patient's vagina.

Description

Booster vaginal applicator for preventing secondary infection

technical field

The utility model relates to the technical field of medical equipment, in particular to a push-type vaginal drug delivery device for preventing secondary infection.

Background technique

Common gynecological diseases mainly include: vaginitis, cervicitis, cervical erosion, endometritis, etc., which have a high incidence rate, are prone to infection, and are easy to relapse, causing great pain to patients. In the prior art, in major hospitals, there are two commonly used treatment methods clinically. One method is to add liquid medicine through a container such as a medicine-adding spoon, and rinse the relevant parts of the vagina with liquid water by pouring. The method is inconvenient to operate, easy to waste medicinal liquid, and it is difficult for the medicinal liquid to reach the relevant lesions inside the vagina, resulting in poor curative effect and poor therapeutic effect. Another method is to directly insert tablets, suppositories, capsules, etc. To the lesion inside the patient's vagina, although this method is simple to operate, it is easy to bring the bacteria on the fingers into the vagina during actual implementation, resulting in cross-infection and secondary infection. At the same time, this method cannot make drug treatment In the relevant lesions outside the vagina, the treatment effect is still not good.

In this way, aiming at the current situation, a new anti-secondary infection booster is designed, which is easy to operate, has good drug delivery effect, can be applied to both intravaginal administration and external vaginal administration, and can prevent cross-infection and secondary infection. Type vaginal applicator is very necessary.

Utility model content

The purpose of this utility model is to overcome the deficiency of the above-mentioned prior art and provide a secondary infection-preventing push type vaginal applicator.

The technical solution adopted by the utility model to solve the problems of the prior art is: a secondary infection-preventing push-type vaginal drug delivery device, which includes a drug-adding syringe and a drug delivery head;

The drug-feeding syringe comprises a syringe, a piston handle and a telescopic protective cover; the front end of the syringe is connected with a nipple to allow the liquid medicine to overflow; the rear end of the syringe is formed as an opening; the The piston handle is accommodated in the syringe, and the end of the piston handle is exposed to the opening; the front end of the telescopic protective sleeve is connected to the rear end of the syringe, and the rear end is connected to the piston handle The rear end of the piston handle is connected so that the front end of the piston handle can be closed and fixed in the syringe in a push-pull manner.

The drug delivery head is a tubular structure, the front end of the drug delivery head of the tubular structure is formed as a smooth plug protruding outward, the rear end is detachably connected to the nipple, and the delivery head of the tubular structure The outer wall of the front end of the drug head is evenly provided with a plurality of overflow holes along its length direction.

The above technical scheme is further elaborated below:

Preferably, the dosing head of the tubular structure includes a dosing tube and a connecting head connected to the dosing tube, the connecting head is threadedly connected to the nipple, and a plurality of overflow holes are evenly distributed in the on the dosing tube.

Preferably, a connector protective sleeve is provided outside the connector, the connector protector has an open end, the open end is in the same direction as the inlet of the connector, and the inlet of the connector is located at the inside the open end of the connector boot described above.

Preferably, the drug delivery tube is made of transparent soft plastic material; the connector, nipple and the syringe are all made of transparent hard plastic material.

Preferably, the outer wall of the end of the drug delivery tube connected to the connecting head protrudes outward, so as to form a side stop.

Preferably, the telescopic protective cover is a high-elastic rubber telescopic hose.

Preferably, the outer surface of the syringe is engraved with capacity scales along its length direction.

Preferably, the outer surface of the syringe is uniformly provided with a plurality of outwardly protruding anti-skid bumps along its length direction.

The beneficial effects of the utility model are:

One, the push-type vaginal drug delivery device for preventing secondary infection provided by the utility model, in actual implementation, directly extend the drug delivery tube at the front end of the drug delivery head into the patient's vagina, then The drug can evenly reach the relevant lesion, and the front end of the drug delivery head is formed as a smooth plug protruding outward, so that when it is inserted, the patient will not feel tingling and pain. When injecting medicine, the front and rear ends of the syringe are sealed to form a closed space inside, so that when the medical staff operates, the bacteria on the fingers will not be brought into the syringe, so that the medicine inside can be kept free It will be polluted, and further, it can be ensured that when the medicine is injected, there will be no cross-infection and secondary infection in the patient's vagina, thus, the utility model has strong practicability and good use effect.

Second, when the utility model is implemented, the outer wall of the end connected to the connection head of the drug delivery tube protrudes outwards, so as to form a side stop, so that when the drug delivery tube is After being inserted into the patient's vagina, the side blocking part just blocks the opening of the vagina, so that the injected medicine can be kept from leaking out, and furthermore, the utility model has a better use effect.

Third, the overall structure of the utility model is simple, easy to implement, and easy to operate, and the outer surface of the syringe of the utility model is evenly provided with a plurality of anti-skid bumps that play an anti-skid role, so that it can be operated with one hand when in use , and make the utility model not easy to slip, at the same time, the utility model has strong practicability, strong specificity, and low manufacturing cost, so that the utility model must have good marketing value, and the utility model will be very popular. can be effectively disseminated.

Description of drawings

Fig. 1 is an overall exploded view of the push type vaginal drug delivery device for preventing secondary infection of the present invention;

Fig. 2 is a schematic diagram of the overall structure of the drug delivery head described in Fig. 1;

The realization of the purpose of the utility model, functional features and advantages will be further described in conjunction with the embodiments and with reference to the accompanying drawings.

Figure number:

Dosing syringe 10;

Syringe 101; capacity scale 1011; piston handle 102; telescopic protective sleeve 103; nipple 104;

Dosing head 20;

Drug delivery tube 201; side stopper 2011; connector 202;

Overflow hole 30;

Joint protective sleeve 40;

open end 401 .

Detailed ways

The technical solution of the utility model will be described in detail below in conjunction with the accompanying drawings and specific embodiments, so as to understand the essence of the utility model more clearly and intuitively.

Fig. 1 is an overall exploded view of the push-type vaginal drug delivery device for preventing secondary infection of the utility model; Fig. 2 is a schematic diagram of the overall structure of the drug delivery head described in Fig. 1;

As shown in Figure 1 and Figure 2;

The push-type vaginal drug delivery device for preventing secondary infection provided by the utility model includes a drug-feeding syringe 10 and a drug delivery head 20;

Wherein, the described syringe 10 includes a syringe 101, a piston handle 102 and a retractable protective sleeve 103; The end is formed as an opening; the piston handle 102 is accommodated in the syringe 101, and the end of the piston handle 102 is exposed to the opening; the front end of the telescopic protective sleeve 103 is in contact with the syringe 101 is connected to the rear end, and the rear end is connected to the rear end of the piston handle 102, so that the front part of the piston handle 102 is fixed in the syringe 101 in a hermetic push-pull manner.

The drug delivery head 20 is a tubular structure, the front end of the drug delivery head 20 of the tubular structure is formed as a smooth plug protruding outward, the rear end is detachably connected to the nipple 104, and the tubular structure A plurality of overflow holes 30 are uniformly opened on the outer wall of the front end of the drug delivery head 20 along its length direction.

Further, during specific implementation, the drug delivery head 20 of tubular structure includes a drug delivery tube 201 and a connection head 202 connected to the drug delivery tube 201, and the connection head 202 is threadedly connected to the nipple 104, A plurality of overflow holes 30 are evenly distributed on the delivery tube 201 .

In this way, in actual operation, the drug delivery tube 201 at the front end of the drug delivery head 20 is directly inserted into the patient's vagina, so that the medicine can evenly reach the relevant lesion. The front end is formed as a smooth plug that protrudes outward, so that when it is inserted, the patient will not feel tingling and pain.

At the same time, when the medicine is injected, because the rear end of the syringe 101 is sealed, the bacteria on the fingers of the medical staff will not be brought into the syringe 101 during operation, so that the medicine inside can be kept from being polluted. , and further, it can be ensured that when the medicine is injected, there will be no cross-infection and secondary infection in the patient's vagina, thus, the utility model has strong practicability and good use effect.

Furthermore, as a preferred solution, in the embodiment of the present utility model, a joint protection cover 40 is provided outside the connector 202, and the joint protection cover 40 has an open end 401, and the open end 401 is connected to the connection The inlets of the connectors 202 are in the same direction, and the connectors 202 are located in the open end 401 of the joint protection sleeve 40 .

In this way, even during the operation, the fingers of the medical staff will not touch the connecting parts of the nipples 104, so that bacteria on the hands and the like can be avoided from being brought into the syringe 101, and even if The anti-pollution effect is better.

Furthermore, as a preferred solution, in this embodiment, the drug delivery tube 201 is made of transparent soft plastic material; the connector 202 , nipple 104 and the syringe 101 are all made of transparent hard plastic material.

In this way, because the drug delivery tube 201 is made of transparent soft plastic material, when the drug delivery tube 201 is inserted into the patient's vagina, it will not bring pain and tingling to the patient, and because the drug delivery tube 201 201, the connector, nipple 104, and the syringe 101 are all made of transparent materials, so that it is easy to check the amount of medicine in the syringe 101 during operation.

It should be emphasized that when the present invention is implemented, the outer wall of the end of the drug delivery tube 201 that is connected to the connecting head protrudes outward, so as to form a side stop 2011 .

Therefore, after the drug delivery tube 201 is inserted into the patient's vagina, the side stopper 2011 just blocks the opening of the patient's vagina, so that the injected medicine can be kept from leaking out, and the utility model has a better use effect .

It should be noted that, in this embodiment, the telescopic protective cover 103 is a high-elastic rubber telescopic hose; the outer surface of the syringe 101 is engraved with a capacity scale 1011 along its length direction, and the outer surface of the syringe 101 The surface is also uniformly provided with a plurality of outwardly protruding anti-skid bumps (not shown) along its length direction.

By adding the anti-skid bumps (not shown), the syringe 101 is not easy to slip when the medical personnel hold the syringe 101 by hand.

What needs to be added is that during specific implementation, when the outside of the patient's vagina is an infected area, the drug delivery tube 201 can also be directly aimed at the relevant lesion outside the patient's vagina for direct drug delivery, and, when necessary, A one-way valve can also be added at the connecting head 202, so that when the drug delivery tube 201 is used to inject drugs into the patient's vagina, the drugs will not flow back, so that the drug-filling syringe 10 can be used multiple times for a patient. Use, when repeated use, only need to replace the new drug delivery head 20 and get final product.

Other embodiments and the like are not described here as examples one by one.

In summary, when the utility model is implemented, the drug delivery tube 201 at the front end of the drug delivery head 20 is directly inserted into the patient's vagina, so that the drug can evenly reach the relevant lesion, and the The front end of the drug delivery head 20 is formed as a smooth plug that protrudes outwards, so that when it is inserted, the patient will not feel tingling and pain. At the same time, when injecting medicine, the front and back of the syringe 101 The end is sealed to form a closed space inside, so that when the medical staff operates, the bacteria on the fingers will not be brought into the syringe 101, so that the medicine inside can be kept from being polluted, and then it can be ensured in the syringe 101. When the medicine is injected, there will be no cross-infection and secondary infection in the patient's vagina, so the utility model has strong practicability and good use effect.

Moreover, the outer wall of the end of the drug delivery tube 201 connected to the connector 202 of the present utility model protrudes outward, so as to form a side stop 2011, so that when the drug delivery tube 201 is inserted After arriving at the patient's vagina, the side blocking part 2011 just blocks the opening of the vagina, so that the injected medicine can be kept from leaking out, and the utility model has a better use effect.

Correspondingly, the overall structure of the utility model is simple, easy to implement, and easy to operate, and the outer surface of the syringe 101 of the utility model is evenly provided with a plurality of anti-skid bumps that play an anti-slip effect, so that when in use, it can be used with one hand operation, and make the utility model not easy to slip, at the same time, the utility model has strong practicability, strong specificity, and low manufacturing cost, so that the utility model must have good marketing value, and the utility model will be very popular , can be effectively popularized.

The above descriptions are only preferred embodiments of the present utility model, and are not therefore limiting the patent scope of the present utility model. Any equivalent structure or equivalent process transformation made by using the specification of the utility model and the contents of the accompanying drawings may be directly or indirectly used in Other relevant technical fields are all included in the patent protection scope of the present utility model in the same way.

Claims (8)

1. an assisted vaginal administration device for anti-superinfection, is characterized in that: it comprises medicine adding syringe and administration head;

Described medicine adding syringe comprises a syringe, a piston handle and a telescopic protective cover; The front end of described syringe is connected with one to make the nipple of liquid medicine spill; The rear end of described syringe is formed as one uncovered; Described piston handle is placed in described syringe, and the end of described piston handle exposes to described uncovered; The front end of described telescopic protective cover is connected with the rear end of described syringe, and rear end is connected with the rear end of described piston handle, with make the fore-end closed of described piston handle can push-and-pull be fixed in described syringe;

Described administration head is a tubular structure, the front end of the described administration head of tubular structure is formed as outwardly round and smooth plug, rear end is connected with described nipple is detachable, and the front end outer wall of the described administration head of tubular structure evenly offers multiple spout hole along its length.

2. the assisted vaginal administration device of anti-superinfection according to claim 1, it is characterized in that: the union joint that the described administration head of tubular structure comprises delivery tube and is connected with described delivery tube, described union joint and described nipple screw thread spin, and multiple described spout hole is distributed on described delivery tube.

3. the assisted vaginal administration device of anti-superinfection according to claim 2; it is characterized in that: described union joint is also provided with a joint protective sleeve outward; described joint protective sleeve has an opening; in the same way, and the access port of described union joint is positioned at the opening of described joint protective sleeve to the access port of described opening and described union joint.

4. the assisted vaginal administration device of the anti-superinfection according to any one of claim 2-3, is characterized in that: described delivery tube is transparent soft plastic material; Described union joint, nipple and described syringe are transparent hard plastic material.

5. the assisted vaginal administration device of anti-superinfection according to claim 4, is characterized in that: the outer wall outwardly convex of one end be connected with described union joint of described delivery tube, to make to be formed as side stopper.

6. the assisted vaginal administration device of anti-superinfection according to claim 5, is characterized in that: described telescopic protective cover is high elastic rubber bellows.

7. the assisted vaginal administration device of anti-superinfection according to claim 5, is characterized in that: the outer surface of described syringe is carved with containing mark along its length.

8. the assisted vaginal administration device of anti-superinfection according to claim 5, is characterized in that: the outer surface of described syringe is also evenly provided with the anti-skidding salient point of multiple outwardly convex along its length.